.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Fuji
McKinsey
Deloitte
Daiichi Sankyo
Merck
Chubb
Johnson and Johnson
Dow
Fish and Richardson

Generated: June 29, 2017

DrugPatentWatch Database Preview

RETET Drug Profile

« Back to Dashboard

What is the patent landscape for Retet, and when can generic versions of Retet launch?

Retet is a drug marketed by Solvay and is included in one NDA.

The generic ingredient in RETET is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.

Summary for Tradename: RETET

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list65
Patent Applications: see list6,488
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RETET at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay
RETET
tetracycline hydrochloride
CAPSULE;ORAL061443-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Solvay
RETET
tetracycline hydrochloride
CAPSULE;ORAL061443-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Chubb
Johnson and Johnson
Healthtrust
Mallinckrodt
US Army
Argus Health
Cerilliant
Covington
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot